The present invention relates to Novel 1,7-dicarba-closo-dodecaborane (meta-carbaborane)-derived carboxylic acids and amines according to Formula (I) suitable for peptide modification for application in boron neutron capture therapy (BNCT). Formula (I) in which X1 is N(H)-, -Ν(G)- or -S-, X2 is -CH2COOH, -CH2-COOG, -(CH2)4-C(COOH)-NH-COO-tertButyl or -(CH2)2-NH2, X CB* is Formula (II) or Formula (III) wherein * marks the position where CB* is coupled to compound of formula (I) X and Y are independently of each other -H and -G and G is natural or synthetic monosaccharide in which the hydroxygroups are protected as well as the related 10B-enriched compounds, and its pharmaceutically acceptable salts, solvates and hydrates and mixtures thereof.
本发明涉及根据式(I)的新型1,7-二碳
硼十二
硼烷(间碳
硼烷)衍生的
羧酸和胺,适用于肽修饰,用于
硼中子俘获疗法(BNCT)。式(I)中X1为N(H)-,-Ν(G)-或-S-,X2为- COOH,-
CH2-COOG,-( )4-C(COOH)-NH-COO-tertButyl或-( )2-NH2,X CB*为式(II)或式(III),其中*标记CB*与式(I)的化合物耦合的位置,X和Y分别独立地为-H和-G,G为天然或合成
单糖,其中羟基团被保护,以及相关的10B富集化合物,以及其药学上可接受的盐、溶剂合物和
水合物及其混合物。